HSE secures urgent court hearing over €22m 6in1 vaccines contract, amid supply concerns

The contract is for supply, over about five years, of about one million doses of the 6in1 vaccine, which relates to Diphtheria, Tetanus, acellular Pertussis, Hepatits B, Inactivated Polio Vaccine and Hameophilus Infuenza Type B.

By Ann O'Loughlin

The HSE has got an urgent court hearing later this month of its bid to lift the automatic suspension of a contract for supply of the "critical" 6in1 vaccines after expressing anxiety about the need to ensure future supplies.